help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on July 25, 2003, doi:10.1164/rccm.200304-467OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200304-467OCv1
168/6/692    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, Y.-Z.
Right arrow Articles by Touqui, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, Y.-Z.
Right arrow Articles by Touqui, L.
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 692-699, (2003)
© 2003 American Thoracic Society

Original Article

Surfactant Protein-A and Phosphatidylglycerol Suppress Type IIA Phospholipase A2 Synthesis via Nuclear Factor-{kappa}B

Yong-Zheng Wu, Samir Medjane, Sophie Chabot, Flavia Saldanha Kubrusly, Isaias Raw, Michel Chignard and Lhousseine Touqui

Unité de Défense Innée et inflammation/INSERM E336, Institut Pasteur, Paris, France; and Centro de Biotecnologia, Instituto Butantan, São Paulo, Brazil

Correspondence and requests for reprints should be addressed to Lhousseine Touqui, Unité de Défense Innée et Inflammation/INSERM E336, Institut Pasteur, 25 Rue du Dr. Roux, 75015 Paris, France. E-mail: touqui{at}pasteur.fr

We previously showed that surfactant inhibits the synthesis of type IIA secretory phospholipase A2 (sPLA2-IIA) by alveolar macrophages. These cells have been identified as the main source of this enzyme in an animal model of acute lung injury. The aim of the present study was to identify the surfactant components involved in the inhibition of sPLA2-IIA expression in alveolar macrophages and the signaling pathways that mediate this inhibition. Our results show that various surfactant preparations can inhibit sPLA2-IIA expression in endotoxin-stimulated alveolar macrophages. Both the surfactant protein (SP)-A and the surfactant phospholipid fraction inhibit this expression. The surfactant phospholipid dioleylphosphatidylglycerol (DOPG) abolishes sPLA2-IIA expression, whereas dipalmitoylphosphatidylcholine does not. Chromatographic analysis and confocal microscopy revealed that phosphatidylglycerol was rapidly incorporated and metabolized by alveolar macrophages and that its metabolites accumulate in the cytosol. Nuclear factor-{kappa}B (NF-{kappa}B) modulates sPLA2-IIA expression in endotoxin-activated alveolar macrophages, and surfactant preparations, surfactant phospholipid fraction, SP-A, and DOPG indeed suppressed NF-{kappa}B activation. In summary, our results show that SP-A and DOPG play a role in the surfactant-mediated inhibition of sPLA2-IIA expression in alveolar macrophages and that this inhibition occurs via a downregulation of NF-{kappa}B activation.

Key Words: surfactant • phospholipase A2 • nuclear factor-{kappa}B • alveolar macrophages




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
B. P. Hurley and B. A. McCormick
Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation
Infect. Immun., June 1, 2008; 76(6): 2259 - 2272.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Ohtsuki, Y. Taketomi, S. Arata, S. Masuda, Y. Ishikawa, T. Ishii, Y. Takanezawa, J. Aoki, H. Arai, K. Yamamoto, et al.
Transgenic Expression of Group V, but Not Group X, Secreted Phospholipase A2 in Mice Leads to Neonatal Lethality because of Lung Dysfunction
J. Biol. Chem., November 24, 2006; 281(47): 36420 - 36433.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-Z. Wu, Y. Manevich, J. L. Baldwin, C. Dodia, K. Yu, S. I. Feinstein, and A. B. Fisher
Interaction of Surfactant Protein A with Peroxiredoxin 6 Regulates Phospholipase A2 Activity
J. Biol. Chem., March 17, 2006; 281(11): 7515 - 7525.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. A. Beharka, J. E. Crowther, F. X. McCormack, G. M. Denning, J. Lees, E. Tibesar, and L. S. Schlesinger
Pulmonary Surfactant Protein A Activates a Phosphatidylinositol 3-Kinase/Calcium Signal Transduction Pathway in Human Macrophages: Participation in the Up-Regulation of Mannose Receptor Activity
J. Immunol., August 15, 2005; 175(4): 2227 - 2236.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Y. Wu, S. Adam, L. Hamann, H. Heine, A. J. Ulmer, U. Buwitt-Beckmann, and C. Stamme
Accumulation of Inhibitory {kappa}B-{alpha} as a Mechanism Contributing to the Anti-Inflammatory Effects of Surfactant Protein-A
Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 587 - 594.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 277 - 287.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society 		  Tobacco